NRGENE AND TEL AVIV SOURASKY MEDICAL CENTER COLLABORATE ON PARKINSON’S GENOMES
November 28, 2017
Tel Aviv Sourasky Medical Center and NRGene research exploring protection again neurodegenerative disease Tel Aviv & Ness Ziona, Israel – NRGene, the worldwide leader in genomic assembly and analysis, has partnered with the Genetic Institute of Tel Aviv Sourasky Medical Center (TASMC) to perform genomic analysis of Parkinson’s disease (PD). “Our collaboration with NRGene and [...]
November 28, 2017
Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today announced it has signed a supply agreement with US Biological, Salem, MA, USA, for its Innova Lightning-Link® technology. Heikki Lanckriet, CEO and CSO of SYGNIS AG, commented: “We are [...]
DANAHER ANNOUNCES LEADERSHIP APPOINTMENT
November 28, 2017
WASHINGTON -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors is appointing Joakim Weidemanis to the position of Executive Vice President of Danaher Corporation, with responsibility for the Company's Product Identification and Water Quality platforms. With this appointment, Mr. Weidemanis will become an Executive Officer of the Company. Mr. Weidemanis, 48 years old, [...]
GE Healthcare acquires bioprocessing start-up Puridify
November 28, 2017
UK start-up is developing nanofiber technology to improve how medicine is manufactured Chalfont St Giles, UK – GE Healthcare has completed the acquisition of Puridify, a bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production. Puridify’s technology, FibroSelect, is complementary to the bead resins and chromatography membranes used today in downstream bioprocessing, [...]
November 28, 2017
Paris, France, and London, UK: Today, Biomillenia, the developer of Smart Microbes™, announced its collaboration with QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) for use of QIAGEN’Ss Microbial Genomics Pro Suite to generate next-generation sequence data on microbes identified using Biomillenia’s proprietary microbe-on-a-chip technology. Biomillenia’s approach can identify strains of microbes previously deemed unculturable, and do so [...]
November 28, 2017
Shimadzu announces the release of the MALDI-8020 matrix assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometer. This product boasts the world's highest level of resolution and sensitivity of a linear benchtop model designed for installation on a laboratory workbench. In comparison to quadrupole and magnetic field systems, MALDI-TOF mass spectrometers have the advantage of [...]
Analytik Jena and BAM Agree to Cooperate in Research
November 28, 2017
Jena – The Bundesanstalt für Materialforschung und -prüfung (Federal Institute for Materials Research and Testing, BAM) and Analytik Jena AG have agreed to cooperate extensively in the research and development of optical spectrometry in the area of elemental analysis. The two parties signed a corresponding cooperation agreement last week in Berlin. The focus of the two [...]
Bruker Announces Contract For 133 Hand-Held Chemical Detectors from the U.S. National Guard
November 28, 2017
BILLERICA, Mass. -- Bruker today announced a contract to deliver 133 RAID™ M-100 hand-held chemical detectors, which are based on Bruker's advanced ion mobility spectrometry (IMS) technology, to the United States National Guard. For deliveries through March 2018, the 133 RAID M-100 units upgrade and enhance the capabilities of the National Guard Homeland Response Force (HRF) and of the CBRNE Enhanced Response [...]
November 28, 2017
Surge in RNAscope and BaseScope Assay publications now includes pharma, biotech and new research areas - and use as a core assay MINNEAPOLIS -- Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is celebrating a milestone in the adoption of its RNAscope® in situ hybridization (ISH) technology. Reaching 1,000 publications and increasing to an average of more than one publication per [...]
Base Pair Biotechnologies Completes $3.2 Million Series A-3 Financing Round and Opens New Facility
November 28, 2017
Accelerates growth in cell analysis, new technology and market development PEARLAND, Texas--Base Pair Biotechnologies, Inc., The Aptamer Discovery Company™, today announced the completion of its $3.2 Million Series A-3 financing round and the opening of its new 5,000 square foot laboratory and office facility in Pearland, TX, a Houston suburb. Toronto-based Eventi Capital Partners Inc. [...]

